Cargando…
Development of an Automated Liquid Biopsy Assay for Methylated Markers in Advanced Breast Cancer
Current molecular liquid biopsy assays to detect recurrence or monitor response to treatment require sophisticated technology, highly trained personnel, and a turnaround time of weeks. We describe the development and technical validation of an automated Liquid Biopsy for Breast Cancer Methylation (L...
Autores principales: | Fackler, Mary Jo, Tulac, Suzana, Venkatesan, Neesha, Aslam, Adam J., de Guzman, Timothy N., Mercado-Rodriguez, Claudia, Cope, Leslie M., Downs, Bradley M., Vali, Abdul Hussain, Ding, Wanjun, Lehman, Jennifer, Denbow, Rita, Reynolds, Jeffrey, Buckley, Morgan E., Visvanathan, Kala, Umbricht, Christopher B., Wolff, Antonio C., Stearns, Vered, Bates, Michael, Lai, Edwin W., Sukumar, Saraswati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426415/ https://www.ncbi.nlm.nih.gov/pubmed/36046124 http://dx.doi.org/10.1158/2767-9764.CRC-22-0133 |
Ejemplares similares
-
Do Breast Cancer Cell Lines Provide a Relevant Model of the Patient Tumor Methylome?
por: Cope, Leslie M., et al.
Publicado: (2014) -
Automated and rapid detection of cancer in suspicious axillary lymph nodes in patients with breast cancer
por: Li, Juanjuan, et al.
Publicado: (2021) -
Optimizing Vitamin D Concentrations for Breast Cancer Risk Reduction
por: Stearns, Vered, et al.
Publicado: (2013) -
DNA methylation markers predict recurrence-free interval in triple-negative breast cancer
por: Fackler, Mary Jo, et al.
Publicado: (2020) -
Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors
por: Downs, Bradley M., et al.
Publicado: (2021)